from Section IV - Precursor Hematopoietic Neoplasms and Related Neoplasms
Published online by Cambridge University Press: 25 November 2023
Acute myeloid leukemia (AML) is a heterogeneous group of diseases representing a clonal expansion of immature, non-lymphoid, bone marrow-derived cells that involve the bone marrow, blood, and extramedullary tissues. In general, blood or bone marrow blast counts ≥ 20% () are required for diagnosing AML, except for AML with t (8;21) (q22; q22.1), AML with inv (16) (p13.1q22) or t (16;16) (p13.1; q22), and acute promyelocytic leukemia (APML) with PML-RARA [1–4]. The World Health Organization (WHO) classification incorporates morphologic, immunophenotypic, genetic, and clinical features to define prognostically significant disease [3–5].
To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.